TGFB1 and neoplasm: Specific inhibition of TGF-β1 in Treg cells highly expressing GARP overcame drug resistance to programmed cell death protein 1 (PD1)/programmed cell death ligand 1 (PD-L1) blockers in tumor patients [123].